Cariprazine: pharmacology and clinical management of psychiatric disorders

Show simplified metadata
dc.contributor.authorAntoun Reyad, Ayman
dc.contributor.authorMishriky, Raafat
dc.date.accepted2018-12-21
dc.date.accessioned2019-02-15T13:49:19Z
dc.date.available2019-02-15T13:49:19Z
dc.date.issued2019-03-11
dc.descriptionThis is an accepted manuscript of an article published by Slack in Psychiatric Annals on 11/02/2019, available online: https://journals.healio.com/doi/10.3928/00485713-20190213-01 The accepted version of the publication may differ from the final published version.en
dc.description.abstractCariprazine is a new atypical antipsychotic for schizophrenia and bipolar disorders 2 management. In this article, the role of cariprazine, a partial D2 and D3 receptors 3 agonist with a higher D3 affinity, in the management of psychiatric conditions is 4 illustrated. Cariprazine caused significant improvements in psychiatric scales such 5 as Positive and Negative Syndrome scale (PANSS), clinical global impressions 6 (CGI) and young mania rating scales (YMRS) and was associated with side effects 7 such as akathisia, restlessness and insomnia. These findings will guide psychiatrists 8 and pharmacists in their clinical role for supporting psychiatric patients care.
dc.formatapplication/PDF
dc.identifier.citationAntoun Reyad, A., Mishriky, R. (2019) 'Cariprazine: pharmacology and clinical management of psychiatric disorders', Psychiatric Annals, 49 (3) pp. 129-134
dc.identifier.doi10.3928/00485713-20190213-01
dc.identifier.issn0048-5713
dc.identifier.journalPsychiatric Annals
dc.identifier.urihttp://hdl.handle.net/2436/622093
dc.language.isoen
dc.publisherHealio
dc.relation.urlhttps://journals.healio.com/doi/10.3928/00485713-20190213-01
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 United States
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/us/
dc.source.beginpage129
dc.source.endpage134
dc.source.issue3
dc.source.volume49
dc.subjectcapirazine
dc.subjectschizophrenia
dc.subjectbipolar disorders
dc.subjectpharmacology
dc.subjectdopamine D3 receptor
dc.titleCariprazine: pharmacology and clinical management of psychiatric disorders
dc.typeJournal article
refterms.dateFCD2019-02-15T13:49:19Z
refterms.dateFOA2021-11-19T15:59:12Z
refterms.versionFCDAM
rioxxterms.funderJisc
rioxxterms.identifier.projectUOW150219AAR
rioxxterms.licenseref.startdate2019-12-31
rioxxterms.licenseref.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/
rioxxterms.versionAM
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Cariprazine.pdf
Size:
240.01 KB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Faculty of Science and Engineering